Agios Pharmaceuticals, Inc. (AGIO) vs Hemab Therapeutics Holdings, Inc. (COAG)
- Agios Pharmaceuticals, Inc. AGIO 31.59 −0.54%
- Hemab Therapeutics Holdings, Inc. COAG 40.86 +3.76%
Agios Pharmaceuticals, Inc. and Hemab Therapeutics Holdings, Inc. are both Biotechnology companies. Agios Pharmaceuticals, Inc. and Hemab Therapeutics Holdings, Inc. are of similar size ($1.9B and $1.8B). Hemab Therapeutics Holdings, Inc. has the higher net margin (0.00% vs −264.8%) and the higher return on invested capital (0.00% vs −75.0%). Across the 10 metrics below, Hemab Therapeutics Holdings, Inc. leads on 8 and Agios Pharmaceuticals, Inc. on 2.
Valuation
Profitability
| Metric | AGIO | COAG | Biotechnology median |
|---|---|---|---|
| Gross margin | 93.81% | — | 67.24% |
| Operating margin | (297.72%) | 0.00% | 0.00% |
| Net margin | (264.76%) | 0.00% | 0.00% |
| Free cash flow margin | (238.54%) | 0.00% | 0.00% |
| Return on equity | (32.95%) | 0.00% | (50.28%) |
| Return on assets | (30.44%) | 0.00% | (45.89%) |
| Return on invested capital | (75.02%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack